Satoh Yoshinari, Hatori Chie, Ito Harunobu
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6 Kashima, Yodogawa-ku, Osaka 532-8514, Japan.
Bioorg Med Chem Lett. 2002 Apr 8;12(7):1009-11. doi: 10.1016/s0960-894x(02)00090-2.
Novel tetrahydrodiazabenzazulene derivatives, designed from the lead compound 1 discovered by screening of our in-house chemical library, were prepared and found to be potent neuropeptide Y-Y5 (NPY-Y5) receptor antagonists. The structure-activity relationships are described. Compounds 7 (FR240662) and 16 (FR252384) were especially attractive owing to their high affinities for the NPY-Y5 receptors, oral absorption and permeability to brain.
从我们内部化学文库筛选出的先导化合物1设计合成了新型四氢二氮杂苯并薁衍生物,发现它们是有效的神经肽Y-Y5(NPY-Y5)受体拮抗剂。描述了构效关系。化合物7(FR240662)和16(FR252384)因其对NPY-Y5受体的高亲和力、口服吸收性和脑通透性而特别引人注目。